Glycyrrhetinic acid induces anoikis-like death and cytoskeletal disruption in the central nervous system tumorigenic cells

Biological and Pharmaceutical Bulletin

Volumn 33, Issue 2, 2010, Pages 321-324

  Yamaguchi, Hideaki ^a   Kidachi, Yumi ^b   Kamiie, Katsuyoshi ^b   Noshita, Toshiro ^c   Umetsu, Hironori ^d   Ryoyama, Kazuo ^b  

^a MEIJO UNIVERSITY   (Japan)

^b AOMORI UNIVERSITY   (Japan)

^c PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^d GIFU SHOTOKU GAKUEN UNIVERSITY   (Japan)

Author keywords

Glycyrrhetinic acid; Human c Ha ras mouse c myc cotransfected highly metastatic serum free mouse embryo 1; Licorice; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; FIBRONECTIN; GLYCYRRHETINIC ACID;

ANIMAL CELL; ANOIKIS; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL DEATH; CENTRAL NERVOUS SYSTEM; CONFOCAL LASER MICROSCOPY; CYTOSKELETON; CYTOTOXICITY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NONHUMAN; WESTERN BLOTTING;

ANIMALS; ANOIKIS; CELL DEATH; CENTRAL NERVOUS SYSTEM NEOPLASMS; CYTOSKELETON; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCYRRHETINIC ACID; HUMANS; MICE; MICE, INBRED BALB C; TUMOR CELLS, CULTURED;

EID: 76049099694     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.33.321     Document Type: Article

References (18)

1. Isbrucker R. A., Burdock G. A., Regul. Toxicol. Pharmacol., 46, 167-192 (2006).
2. Shibata S., Yakugaku Zasshi, 120, 849-862 (2000).
3. Armanini D., Fiore C., Mattarello M. J., Bielenberg J., Palermo M., Exp. Clin. Endocrinol. Diabetes, 110, 257-261 (2002).
4. Loo D. T., Fuquay J. I., Rawson C. L., Barnes D. W., Science, 236, 200-202 (1987).
5. Loo D., Rawson C., Helmrich A., Barnes D., J. Cell. Physiol., 139, 484-491 (1989).
6. Rawson C., Cosola-Smith C., Barnes D., Exp. Cell Res., 186, 177-181 (1990).
7. Rawson C., Shirahata S., Collodi P., Natsuno T., Barnes D., Oncogene, 6, 487-489 (1991).
8. Nomura T., Matano S., Okada G., Tokuyama H., Hori I., Nakamura S., Kameyama T., Ryoyama K., In Vitro Cell. Dev. Biol., 29A, 614-616 (1993).
9. Ham R. G., McKeehan W. L., Methods Enzymol., 58, 44-93 (1979).
10. Mather J. P., Sato G. H., Exp. Cell Res., 124, 215-221 (1979).
11. Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B., Cancer Res., 47, 943-946 (1987).
12. Yamaguchi H., Kidachi Y., Umetsu H., Ryoyama K., Biol. Pharm. Bull., 31, 1008-1012 (2008).
13. Frisch S. M., Francis H., J. Cell Biol., 124, 619-626 (1994).
14. Bijman M. N., van Berkel M. P., van Nieuw Amerongen G. P., Boven E., Biochem. Pharmacol., 76, 707-716 (2008).
15. Flusberg D. A., Numaguchi Y., Ingber D. E., Mol. Biol. Cell, 12, 3087-3094 (2001).
16. Deschesnes R. G., Patenaude A., Rousseau J. L. C., Fortin J. S., Ricard C., Cote M. F., Huot J., C.-Gaudreault R., Petitclerc E., J. Pharmacol. Exp. Ther., 320, 853-864 (2007).
17. Gu H., Gong L., Yu J., J. Forest. Res., 13, 141-143 (2002).
18. de Groot G., Koops R., Hogendoorn E. A., Goewie C. E., Savelkoul T. J., van Vloten P., J. Chromatogr., 456, 71-81 (1988).